ℹ️
🇨🇿
Hledání
Hledat publikace relevantní k dotazu "extended follow-up"
extended follow-up
Publikace
Předměty
Osoby
Publikace
Studium
publication
Bezpečnost a účinnost vemurafenibu u pacientů s maligním melanomem s mutacemi BRAF V600E a BRAF V600K - prodloužené sledování studie BRIM-3
2014 |
Publikace bez příslušnosti k fakultě
publication
Extended follow-up of the CYCLOFA-LUNE trial comparing two sequential induction and maintenance treatment regimens for proliferative lupus nephritis based either on cyclophosphamide or on cyclosporine A
2014 |
1. lékařská fakulta, 3. lékařská fakulta, Lékařská fakulta v Hradci Králové
publication
Ixazomib, Lenalidomide and Dexamethasone in Relapsed and Refractory Multiple Myeloma in Routine Clinical Practice: Extended Follow-Up Analysis and the Results of Subsequent Therapy
2022 |
1. lékařská fakulta, 3. lékařská fakulta, Lékařská fakulta v Hradci Králové
publication
Lenvatinib plus pembrolizumab versus sunitinib as first-line treatment of patients with advanced renal cell carcinoma (CLEAR): extended follow-up from the phase 3, randomised, open-label study
2023 |
1. lékařská fakulta
publication
Povolání a riziko karcinomu horní části zažívacího traktu: studie ARCAGE
2012 |
1. lékařská fakulta
publication
CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma: 6-year results of an open-label randomised study of the MabThera International Trial (MInT) Group
2011 |
1. lékařská fakulta
publication
Sustained Progression-Free Survival Benefit of Rituximab Maintenance in Patients With Follicular Lymphoma: Long-Term Results of the PRIMA Study
2019 |
Lékařská fakulta v Hradci Králové
publication
Resolute zotarolimus-eluting coronary stent system for the treatment of coronary artery disease
2014 |
3. lékařská fakulta
publication
Elotuzumab, lenalidomide, and dexamethasone in RRMM: final overall survival results from the phase 3 randomized ELOQUENT-2 study
2020 |
1. lékařská fakulta
publication
Lowering cholesterol, blood pressure, or both to prevent cardiovascular events: results of 8.7 years of follow-up of Heart Outcomes Evaluation Prevention (HOPE)-3 study participants
2021 |
Publikace bez příslušnosti k fakultě
publication
Recurrent YAP1-TFE3 Gene Fusions in Clear Cell Stromal Tumor of the Lung
2021 |
Lékařská fakulta v Plzni
publication
Effectiveness of multiple disease-modifying therapies in relapsing-remitting multiple sclerosis: causal inference to emulate a multiarm randomised trial
2023 |
1. lékařská fakulta